TTP Patients' hidden vessel damage revealed by advanced scans
NCT ID NCT07615244
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to measure damage to tiny blood vessels in people with thrombotic thrombocytopenic purpura (TTP), both during active disease and in remission. Researchers will use brain MRI, eye scans, and nailfold capillary exams to detect abnormalities. 79 participants will be followed for three years with five study visits. No drugs are being tested; the goal is to better understand how TTP affects the body's microcirculation over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and monitor organ damage in TTP patients, potentially improving long-term care.
- What could go wrong
- This is an observational study with no treatment being tested, so it will not directly lead to a new therapy. The results may not apply to all TTP patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Milano, 20122, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.